Avecho Biotechnology Ltd (AVE)

Currency in AUD
0.013
0.000(0.00%)
Closed·
AVE is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.0120.013
52 wk Range
0.0060.027
Key Statistics
Bid/Ask
0.012 / 0.013
Prev. Close
0.013
Open
0.013
Day's Range
0.012-0.013
52 wk Range
0.006-0.027
Volume
402.81K
Average Vol. (3m)
4.04M
1-Year Change
116.6667%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
AVE Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock has fared poorly over the last month

Avecho Biotechnology Ltd News & Analysis

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell

Earnings

Latest Release
Aug 25, 2026
EPS / Forecast
-- / --
Revenue / Forecast
59.6K / --
EPS Revisions
Last 90 days

AVE Income Statement

Compare AVE to Peers and Sector

Metrics to compare
AVE
Peers
Sector
Relationship
P/E Ratio
−13.7x−2.7x−0.2x
PEG Ratio
−3.73−0.110.00
Price / Book
26.3x2.9x2.6x
Price / LTM Sales
68.1x2.6x2.8x
Upside (Analyst Target)
-116.6%65.5%
Fair Value Upside
Unlock16.8%8.9%Unlock

Avecho Biotechnology Limited, a biotechnology company, develops and commercializes human and animal health products using its proprietary drug delivery system, tocopherol phosphate mixture (TPM) in Australia, Switzerland, France, and India. It operates through Production and Human Health segments. The company manufactures and sells TPM and Vital ET products for use in drug delivery and cosmetic formulations. Its human health portfolio covers delivery of pharmaceutical products through gels, injectables, and patches. In addition, the company develops pharmaceutical products; oral, topical, and edible pharmaceutical cannabinoid products, including a cannabidiol TPM soft-gel capsule in Phase III clinical trial for the treatment of insomnia; and non-antibiotic feed additive products to enhance feed efficiency and the health of livestock animals. The company was formerly known as Phosphagenics Limited and changed its name to Avecho Biotechnology Limited in May 2019. Avecho Biotechnology Limited was incorporated in 1992 and is based in Clayton, Australia.

Employees
15
Market
Australia

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
205.86K0.01%2.68K
Other Institutional Investors
562.72M14.56%7.32M
Public Companies & Retail Investors
3.30B85.43%42.91M
Total
3.86B100.00%50.23M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Paradyce Pty. Ltd.9.04%349,133,1884,539
Rosscope Pty Ltd2.33%89,973,9861,170

FAQ

What Is the Avecho (AVE) Stock Price Today?

The Avecho stock price today is 0.013 AUD.

What Stock Exchange Does Avecho Trade On?

Avecho is listed and trades on the Sydney Stock Exchange.

What Is the Stock Symbol for Avecho?

The stock symbol for Avecho is "AVE."

What Is the Avecho Market Cap?

As of today, Avecho market cap is 50.230M AUD.

What Is Avecho's Earnings Per Share (TTM)?

The Avecho EPS (TTM) is -0.0010.

From a Technical Analysis Perspective, Is AVE a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Avecho Stock Split?

Avecho has split 1 times.

How Many Employees Does Avecho Have?

Avecho has 15 employees.

What is the current trading status of Avecho (AVE)?

As of Nov 03, 2026, Avecho (AVE) is trading at a price of 0.013 AUD, with a previous close of 0.013 AUD. The stock has fluctuated within a day range of 0.012 AUD to 0.013 AUD, while its 52-week range spans from 0.006 AUD to 0.027 AUD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.